Petmed Express (PETS) Common Equity (2011 - 2025)

Petmed Express has reported Common Equity for 15 years, with the latest figure at $32.8 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 82.37% year-over-year to $32.8 million; the trailing twelve-month figure through Dec 2025 stood at $32.8 million (up 82.37% YoY), and the FY2025 full-year result was $85.1 million, up 18.98% from the prior year.
• Common Equity for Q4 2025 stood at $32.8 million, up from $23.9 million in the prior quarter.
• The five-year high for Common Equity was $130.7 million in Q4 2021, with the low at $20000.0 in Q2 2021.
• Historically, Common Equity has averaged $58.6 million across 5 years, with a median of $52.2 million in 2024.
• Annual changes were most pronounced in 2021 — Common Equity slumped 99.98% — and 2023, when it jumped 374109.52%.
• Petmed Express' Common Equity stood at $130.7 million in 2021, then fell by 12.13% to $114.9 million in 2022, then plunged by 79.57% to $23.5 million in 2023, then retreated by 23.46% to $18.0 million in 2024, then jumped by 82.37% to $32.8 million in 2025.
• The last three Common Equity figures came in at $32.8 million (Q4 2025), $23.9 million (Q3 2025), and $32.4 million (Q2 2025), per Business Quant data.